Medtronic's (MDT) Revo MRI SureScan Gets Approval With Conditions from U.S. FDA
Tweet Send to a Friend
Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
